Pinz Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Pinz Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-28,805	Closed	-$3.46M	–	586
2021 Q1	$3.46M	Buy	+28,805	New	+$3.26M	0.92%	46
2020 Q2	–	Sell	-573	Closed	-$41K	–	212
2020 Q1	$41K	Sell	573 -15,087	-96%	-$1.29M	0.11%	96
2019 Q4	$1.18M	Buy	+15,660	New	+$686K	0.43%	100

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pinz Capital Management's KRTX Position: Q2 2021 in Review

Pinz Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2021, closing a stake of 28,805 shares — an estimated $3.46M sold.

Pinz Capital Management first reported a position in KRTX in Q4 2019 and held it in 3 quarters. The position peaked at $3.46M in Q1 2021. 159 funds tracked by Wall St. Rank hold KRTX as of Q2 2021.

Pinz Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Pinz Capital Management sold 28,805 Karuna Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $3.46M.
Pinz Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
Pinz Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $3.46M in Q1 2021.
159 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Pinz Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.